Ketamine was first synthesized in 1962 by Professor Calvin L. Stevens, and in 1970 the medication was granted FDA approval as a surgical anesthetic. In the decades that followed, researchers began to uncover the drug’s extraordinary potential to treat mental health...
According to the Centers for Disease Control, 15-20 million people are diagnosed with and treated for depression every year. This makes depression the most common mental illness in the United States. However, for roughly 30 percent of these patients, standard...
In an exciting development, Regional Anesthesia and Pain Medicine published the first set of guidelines for the use of ketamine for treating pain—a framework for doctors and institutions, who should get it, and who should not. Ketamine infusions have emerged as a...
It’s estimated that 36 million people in the United States struggle with opiate addiction. More than 80% of these addictions started with a prescribed opiate painkiller. With the opioid crisis officially declared a National State of Emergency, it’s important to know...
“Incredibly effective.” “Truly remarkable.” These are just a few of the comments made about the results of the latest ketamine trial – the first ever randomized control trial to study the effect of ketamine on people aged 60+ suffering from treatment resistant...
